Latest Commercialisation News

LTR Pharma has locked in Strive Specialties as its exclusive US pharmacy fulfilment partner for ROXUS, marking a critical step towards commercial launch in the US erectile dysfunction market.

NOVONIX has achieved a key milestone by delivering a mass production synthetic graphite anode sample to Panasonic, marking the first such North American production and advancing U.S. battery supply chain ambitions.

Ark Mines has produced high-grade monazite and titanium dioxide products from its Sandy Mitchell heavy mineral concentrate, marking a key step toward commercialising its North Queensland rare earths project.

Micro-X has cleared a critical design review for its Full Body CT system, unlocking a $1.6 million milestone payment from US government partner ARPA-H and moving into prototype manufacturing.

Simble Solutions is on the cusp of revealing initial results from its NanoSensor technology development, targeting major markets including Industrial IoT, defence sensing, and wearable medical devices.

dorsaVi has secured exclusive rights to two key robotics patents from NTU Singapore, filling critical gaps in safety control and data acquisition to expand into collaborative robotics and exoskeleton markets.

Eden Innovations has wrapped up the second tranche of its $4 million institutional placement, issuing over 14 million shares at 18 cents each. The capital injection finalises the raise announced in April, with shares issued under ASX rules and ranking equally with existing stock.

Sparc Technologies secures its first international commercial partner as Petro Vietnam Paint commits to using ecosparc® in its PERAPHENE coatings range, targeting highly corrosive environments with improved anticorrosion performance.

Carnaby Resources has solidified its Miniboom Lode discovery with wide, high-grade copper-gold intersections near Mount Hope Central and extended the Trek 1 mineralisation with substantial new drill results, underpinning its mid-year feasibility study and 2026 production target.

LTR Pharma has secured a binding US telehealth commercialisation framework for its intranasal erectile dysfunction treatment ROXUS, committing to at least 150,000 prescriptions in the first year and granting exclusivity to Shed Holdings' platform.

Nanoveu Limited has completed tape-out of its next-generation 16nm ECS-DoT AI chip, progressing its ultra-low-power edge AI commercialisation, while bolstering its drone systems capabilities through the Spinoff Robotics acquisition.

EBR Systems has secured A$106.4 million through a fully underwritten institutional placement and entitlement offer, positioning the company for further commercial expansion of its wireless cardiac pacing technology.